title: Pharmacokinetics and pulmonary disposition of tedizolid and linezolid in a murine pneumonia model under variable conditions.
abstract: In vivo pharmacokinetics are often evaluated in only one variation of an infection model, and the resulting exposures are assumed to be similar in each model. We evaluated and compared the effect of lung infection and immune status on the murine pharmacokinetics and pulmonary disposition of tedizolid and linezolid. Both factors resulted in differing blood and pulmonary exposure profiles, with similar trends for tedizolid and linezolid. These data highlight the importance of pharmacokinetic confirmation in each model.
authors.affiliation: California Northstate College of Pharmacy, Rancho Cordova, California, USA.
authors.forename: Rebecca A
authors.initials: RA
authors.lastname: Keel
authors.forename: Jared L
authors.initials: JL
authors.lastname: Crandon
authors.forename: David P
authors.initials: DP
authors.lastname: Nicolau
mesh_terms: D000081:Acetamides / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D000818:Animals; D000890:Anti-Infective Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D005260:Female; D000069349:Linezolid; D051379:Mice; D008807:Mice, Inbred BALB C; D023303:Oxazolidinones / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D011014:Pneumonia / Q000097:blood / Q000188:drug therapy*; D013777:Tetrazoles / Q000493:pharmacokinetics* / Q000627:therapeutic use*
chemical_list: D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D013777:Tetrazoles; C546016:tedizolid; D000069349:Linezolid